2020 Annual Meeting | P16 - Poster Session 16

Date Thursday 04/30/20

Time 05:30 PM - 06:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Neuromuscular and Clinical Neurophysiology (EMG), Aging, Dementia, and Behavioral Neurology, Autoimmune Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Headache, Movement Disorders, Multiple Sclerosis, Neuro Trauma, Critical Care, and Sports Neurology

CME Available 0.00 credit

Event Timeline
05:30 PM - 06:30 PM	Abstract	9-001 - Modification of Facial emotion observation strategies in demyelinating disease spectrum : an eye-tracking study. Mikael Cohen
05:30 PM - 06:30 PM	Abstract	9-002 - Serum soluble TWEAK in relapsing and progressive multiple sclerosis patients. Xavier Ayrignac
05:30 PM - 06:30 PM	Abstract	9-003 - IgG index for multiple sclerosis diagnosis: old test do the trick Yang Zheng, MD, PhD
05:30 PM - 06:30 PM	Abstract	9-004 - A single-center, prospective, cross-sectional study to evaluate the reliability and validity of the modified Manual Muscle Test for persons with multiple sclerosis
05:30 PM - 06:30 PM	Abstract	9-005 - The Rise of Connected Tools in Medicine : Evaluating Neurological Deficits in Lower Limbs With The MYO Armband in Multiple Sclerosis Patients Salimata Gassama, MD
05:30 PM - 06:30 PM	Abstract	9-006 - Foot-tapping ability is associated with walking ability in relapsing-remitting and progressive multiple sclerosis Sumire Sato
05:30 PM - 06:30 PM	Abstract	9-007 - Neurofilament Light Chain and Levels of Fatigue are Reduced by Dimethyl Fumarate Independent of Inflammatory Neuroaxonal Damage Tobias Sejbaek, MD, PhD
05:30 PM - 06:30 PM	Abstract	9-008 - Safety and Efficacy of Ocrelizumab in Patients who Transitioned Directly from Alemtuzumab Therapy Paul Miller
05:30 PM - 06:30 PM	Abstract	9-009 - Increased Burden of Susceptibility Variants in Familial Multiple Sclerosis Elif Everest, PhD
05:30 PM - 06:30 PM	Abstract	9-010 - From Therapy Enrollment to First Dose - a Quality Improvement Initiative for MS Care Jamie Bolling
05:30 PM - 06:30 PM	Abstract	9-011 - The Best Motion Sensor Localization For Ataxic Gait Assessment Ondrej Dostal
05:30 PM - 06:30 PM	Abstract	9-012 - An Attempt to Subclassify and Understand Further the MS/NMOSD “Overlap” Syndromes and Beyond… Bade Gulec
05:30 PM - 06:30 PM	Abstract	9-013 - Should Elderly MS Patients Follow Conventional Dosing of Ocrelizumab? Soumya Bouchachi, MD
05:30 PM - 06:30 PM	Abstract	9-014 - Two-Year Interim Results of the MS-CQI Research Collaborative Brant Oliver
05:30 PM - 06:30 PM	Abstract	9-015 - Associations Between Vascular Comorbidity, Visual Acuity and Optical Coherence Tomography in Secondary Progressive Multiple Sclerosis Kathleen Shangraw
05:30 PM - 06:30 PM	Abstract	9-016 - Network Meta-Analysis for Cumulative Disability Accumulation in Relapsing Multiple Scelorsis Alexander Keenan
05:30 PM - 06:30 PM	Abstract	9-018 - Natural Course of Relapsing Tumefactive Multiple Sclerosis and Tumefactive Demyelinating Lesions Ozgu Kizek, MD
05:30 PM - 06:30 PM	Abstract	9-019 - Can Sjogren's Mimic MS or be an MS+ Syndrome? Armistead Williams III, MD
05:30 PM - 06:30 PM	Abstract	15-001 - Cognitive Impairment in Neuro-Behcet's and Behcet's Disease Merve Atik, MD
05:30 PM - 06:30 PM	Abstract	15-002 - Demographics, Clinical Characteristics and Neurologic Manifestations of CVID-Associated Granulomatous Disease in a Multi-Institutional Dataset Tammy L. Smith, MD, PhD
05:30 PM - 06:30 PM	Abstract	15-003 - Cognitive and Depressive Symptoms in Adults with Common Variable Immunodeficiency (CVID) Bruno I. De Almeida
05:30 PM - 06:30 PM	Abstract	15-004 - ANCA Negative Eosinophilic Granulomatosis with Polyangiitis in Patient with Multiple Autoimmune Disorders. Shaweta Khosa
05:30 PM - 06:30 PM	Abstract	15-005 - Simultaneous Central and Peripheral Demyelination in A Patient with Systemic Lupus Erythematosus Masumeh Hatami, MD
05:30 PM - 06:30 PM	Abstract	15-006 - CLIPPERS in the Setting of Systemic Lupus Erythematosus Ronald Alvarado Dyer, MD
05:30 PM - 06:30 PM	Abstract	15-007 - Tumefactive CNS Demyelination in Pregnancy: A Diagnostic and Therapeutic Challenge Terri Milburn
05:30 PM - 06:30 PM	Abstract	15-008 - Fulminant CNS Demyelination After Discontinuation of TNF-Inhibitor(TNFi) therapy Michael B. Beeler, DO
05:30 PM - 06:30 PM	Abstract	15-009 - Parry-Romberg Syndrome: Case Report and Review Marcus Cimino, MD
05:30 PM - 06:30 PM	Abstract	15-010 - Recurrent Post-Partum Rhombencephalitis Associated With Anti-Centromere Antibody: A Case Report Alier Marrero, MD
05:30 PM - 06:30 PM	Abstract	15-011 - An Unusual presentation of Rheumatoid Meningitis in the Pre-clinical period of Rheumatoid Arthritis Luis G. Manrique, MD
05:30 PM - 06:30 PM	Abstract	15-012 - Melkersson-Rosenthal Syndrome with Hearing Impairment. Sania Atta, MBBS
05:30 PM - 06:30 PM	Abstract	15-013 - IgG4 Related Disease Presenting As a Cerebral Mass With Leptomeningeal Enhancement Gina S. Perez-Giraldo, MD
05:30 PM - 06:30 PM	Abstract	3-001 - Transcriptomic Analysis Of Dystonia-Related Genes Reveals Functional Convergence Within Specific Cell Types And Shared Neurobiology With Psychiatric Disorders Niccolò Mencacci
05:30 PM - 06:30 PM	Abstract	3-002 - Family-Based Genome Analysis Identifies Clinically Relevant de novo Variants in Pediatric Dystonia Bahareh Adhamimojarad, PhD
05:30 PM - 06:30 PM	Abstract	3-003 - Longterm Adherence and Global Self Perceived Response to Botulinum Neurotoxin are Determined by the Treatment Indication, up to 23 Years Real World Evidence from a Single Center Retrospective Cohort Study
05:30 PM - 06:30 PM	Abstract	3-004 - TAF1 expression in X-Linked Dystonia-Parkinsonism Jamal Al Ali, MD
05:30 PM - 06:30 PM	Abstract	3-005 - Impact of Injection Schedule Flexibility on Patient Satisfaction with Botulinum Toxin Treatment for Cervical Dystonia Vivay Peter Misra, MD
05:30 PM - 06:30 PM	Abstract	3-006 - Mortality in Restless Leg Syndrome: A-11 year-year follow up study. Esther Cubo Delgado, MD, PhD, FAAN
05:30 PM - 06:30 PM	Abstract	3-007 - Puerto Rican family cohort presenting with rapid-onset dystonia-parkinsonism due to an ATP1A3 Pathogenic Variant Alexandra Montalvo Acevedo, MD
05:30 PM - 06:30 PM	Abstract	3-008 - Two Heterozygous SNYE1 Mutations Presenting as Spasmodic Adductor Dysphonia, Task-specific Jaw Dystonia, Generalized Dystonia, and Ataxia in a Jamaican Man. Sviatoslav Redko, MD
05:30 PM - 06:30 PM	Abstract	3-009 - Decreased Therapeutic Effect Over Time Amongst Botulinum Toxin Agents Rashid Kazerooni
05:30 PM - 06:30 PM	Abstract	3-011 - Malignant Tics: Two Cases with Management Strategies to Prevent Long Term Complications Mariam Hull, MD
05:30 PM - 06:30 PM	Abstract	3-012 - Expanding the Phenotypic Presentation in KCNA2 Mutation: Tics and Stereotypies Joseph Legacy, MD
05:30 PM - 06:30 PM	Abstract	3-013 - Cost-Utility Analysis of Flexible Intervals with IncobotulinumtoxinA Versus Fixed Dosing with OnabotulinumtoxinA in the Management of Cervical Dystonia and Blepharospasm in Major Canadian Markets Marie-Eve Gendron
05:30 PM - 06:30 PM	Abstract	3-014 - Social Cognition Is Abnormal in Cervical Dystonia but Not Blepharospasm Jeanne Feuerstein, MD
05:30 PM - 06:30 PM	Abstract	3-015 - Botulinum Toxin Therapy for Medication and DBS Refractory Foot Dystonia of Parkinsonism Muthu Kuzhali Ganapathy, MBBS
05:30 PM - 06:30 PM	Abstract	3-016 - Chemo-denervation of Oromandibular Dystonia with Botulinum toxins: Five-year experience
05:30 PM - 06:30 PM	Abstract	3-017 - A Unique Case of Tourette’s Motor Tic Myelopathy with a Cervical Contrast-Enhancing Lesion, Resolving with Medical Therapy Robert J. Ure, MD
05:30 PM - 06:30 PM	Abstract	12-001 - Standardized Ictal Assessment: Improving the Quality of an Epilepsy Monitoring Unit Brian J. Hanrahan, MD
05:30 PM - 06:30 PM	Abstract	12-002 - ED Visits and Readmissions Following Epilepsy Monitoring Unit Discharge Alison M. Fields, NP
05:30 PM - 06:30 PM	Abstract	12-003 - Epileptic seizures after cardiovascular surgery Carla F. Bolano Diaz, MD
05:30 PM - 06:30 PM	Abstract	12-004 - Incidence of Seizure and Associated Risk Factors in Patients in the Medical Intensive Care Unit (ICU) at Memorial Sloan Kettering Cancer Center (MSKCC) In 2016-2017 Saeedeh Azary, MD, MPH
05:30 PM - 06:30 PM	Abstract	12-005 - A Hospital Based Cross-sectional Study Among Women With Epilepsy In Addis Ababa, Ethiopia Hanna D. Belay, MD
05:30 PM - 06:30 PM	Abstract	12-006 - What Happens to Glucose During Multidien Interictal or Ictal Cycles?
05:30 PM - 06:30 PM	Abstract	12-007 - Knowledge of Women Issues and Epilepsy among Doctors in Gujarat Samir Patel, MD, DNB, FEBN, MRCP, FRCP, FAAN
05:30 PM - 06:30 PM	Abstract	12-008 - Caregivers and Compounding Pharmacies: Identifying Unmet Needs
05:30 PM - 06:30 PM	Abstract	12-009 - Vaping and Seizure Risk: A Case Report Timothy Quezada, MD
05:30 PM - 06:30 PM	Abstract	6-001 - Hepatic Reflections in Brain: The Clinicoradiological Spectrum
05:30 PM - 06:30 PM	Abstract	6-002 - Liver Damage in High Blood Pressure Diseases in Pregnancy is related with Cognitive Capacity Decreasement
05:30 PM - 06:30 PM	Abstract	6-003 - The Risk of Renal Hemorrhage in Adult Patients Burdened by Kidney Manifestations of Tuberous Sclerosis. Lauren A. Neal
05:30 PM - 06:30 PM	Abstract	6-004 - Determinants of post lumbar puncture headache – the role of cerebrospinal fluid volume Gadi Miron
05:30 PM - 06:30 PM	Abstract	6-005 - Transient Neurological Sequela After Interscalene Block: A case series Sri Raghav S. Sista, MD
05:30 PM - 06:30 PM	Abstract	6-006 - Retinal Pathology Occurs in Stiff Person Syndrome Jeffrey Lambe, MD
05:30 PM - 06:30 PM	Abstract	6-007 - Hashimoto’s Encephalopathy: A Spectrum Disorder? Ali M. Al-Salahat, MBBS
05:30 PM - 06:30 PM	Abstract	6-008 - Classic and overlapping Miller Fisher syndrome: Clinical and electrophysiological features
05:30 PM - 06:30 PM	Abstract	6-009 - Elucidating the Role of Myeloperoxidase in Distinguishing Acute Encephalitis Syndrome of Infectious, Immune mediated and Unknown Etiology
05:30 PM - 06:30 PM	Abstract	6-010 - Neurological Symptoms in Patients with Zinc deficiency: A Case Series with Documented Blood Levels Madhureeta Achari, MD, FAAN
05:30 PM - 06:30 PM	Abstract	6-011 - Copper levels in maintenance plasmapheresis Chen Yan, MD
05:30 PM - 06:30 PM	Abstract	7-001 - Neuropathic Otalgia: Rare and Treatable Ear Pains Aarushi Suneja, MD
05:30 PM - 06:30 PM	Abstract	7-002 - America's Headache Shirley Ju, MD
05:30 PM - 06:30 PM	Abstract	7-003 - The Headache That Broke My Heart: Cluster and Bradycardia Jyotika Singh
05:30 PM - 06:30 PM	Abstract	7-004 - Minotaur Syndrome as a difficult to treat headache: prospects for diagnosis and treatment. Rogelio Dominguez-Moreno, MD
05:30 PM - 06:30 PM	Abstract	7-005 - Clinical Features of Headaches in Elderly Patients. PREMECEF Results. Luis Fernandez
05:30 PM - 06:30 PM	Abstract	7-006 - Anxiety, Depression and Lifestyle Patterns among Adolescents from India with Primary Headache Sachin M. Kokane
05:30 PM - 06:30 PM	Abstract	7-007 - Relation of Headache Frequency to Cognitive Status in Veterans of Iraq (OIF) and Afghanistan (OEF) wars who have had a Deployment-Related TBI (DTBI) James R. Couch, Jr., MD, PhD, FAAN
05:30 PM - 06:30 PM	Abstract	7-008 - Factors Associated with Subsequent Cerebral Vascular Disease after Emergency Department Headache Visits: a nested case-control study Jenny L. Rotblat, MD
05:30 PM - 06:30 PM	Abstract	7-009 - Sleep Disorders in Mexican Pediatric Patients with Headache.
05:30 PM - 06:30 PM	Abstract	7-010 - Coining the Pablo Picasso Syndrome Ashhar Ali, DO, FAAN
05:30 PM - 06:30 PM	Abstract	7-011 - A Case of High Intracranial Pressure and Dural Ectasia Sandhya Ravikumar, MD
05:30 PM - 06:30 PM	Abstract	7-012 - Needle Design and the Occurence of Post-dural Puncture Headache - a Randomized, Double-blind Study Comparing 22G Sprotte and Quincke Ane Skaare Sjulstad, MD
05:30 PM - 06:30 PM	Abstract	7-013 - Prevalence of Primary Headache Disorder Among School Children of Kuwait.
05:30 PM - 06:30 PM	Abstract	1-001 - Striving to improve outcome measures for inclusion body myositis through novel dynamometer and modifications of the current functional rating scale Ava Y. Lin, MD
05:30 PM - 06:30 PM	Abstract	1-002 - Spinal Cord Pathology in Sporadic Inclusion Body Myositis Sahara Cathcart, MD
05:30 PM - 06:30 PM	Abstract	1-003 - Clinical Correlates of Variant KLRG1-expressing T cells in Inclusion Body Myositis Namita Goyal, MD, FAAN
05:30 PM - 06:30 PM	Abstract	1-004 - Cricopharyngeal bar in inclusion body myositis: A red flag Kenichiro Taira, MD, PhD
05:30 PM - 06:30 PM	Abstract	1-005 - Application of electrical impedance myography to capture disease progression in inclusion body myositis Bhaskar Roy, MD, FAAN
05:30 PM - 06:30 PM	Abstract	1-006 - Sporadic Inclusion Body Myositis with skeletal muscle interstitial Amyloidosis Mazen S. Alamr, MBBS
05:30 PM - 06:30 PM	Abstract	1-007 - Expanding the Phenotype of MDA5 Antibody Positive Dermatomyositis Gema E. Giler, MD
05:30 PM - 06:30 PM	Abstract	1-008 - Acute Overlap Syndrome with Myopathy Associated with Anti-signal Recognition Particle Antibodies and Sarcoidosis Catherine Daley, MD
05:30 PM - 06:30 PM	Abstract	1-009 - Successful recovery of anti-SRP myopathy with subcutaneous methotrexate after 17 years of poor response to immunomodulation. Yohei Harada, MD
05:30 PM - 06:30 PM	Abstract	1-010 - Acute Necrotizing Myositis in Systemic Lupus Erythematous Jonathan Cauchi, MD
05:30 PM - 06:30 PM	Abstract	1-011 - Myopathy: an underrecognized manifestation of vasculitis Marcus Vinicius R. Pinto, MD
05:30 PM - 06:30 PM	Abstract	1-012 - Prevalence and Autoantibody Associations of Ectopic Lymphoid Structures among Patients with Idiopathic Inflammatory Myopathies Naohiro Uchio, MD, PhD
05:30 PM - 06:30 PM	Abstract	1-013 - Voriconazole-Induced Periostitis Presenting as Diffuse Myalgias Ashley E. Anderson, MD
05:30 PM - 06:30 PM	Abstract	1-014 - Correlation of Spontaneous Activity on Needle Electromyography with Pathological Changes on Muscle Biopsies Maria Kristina C. Dorotan, MD
05:30 PM - 06:30 PM	Abstract	10-001 - Argentine Validation of the Spanish Version of the Montreal Cognitive Assessment Test (MoCA-S) and its usefulness in Mild Cognitive Impairment and Dementia in Elderly.
05:30 PM - 06:30 PM	Abstract	10-002 - Confrontation Naming Deficit in Lewy Body Dementia Patients with Alzheimer’s Disease Co-Pathology
05:30 PM - 06:30 PM	Abstract	10-003 - A fully automated cognitive screening tool based on assessment of speech and language
05:30 PM - 06:30 PM	Abstract	10-004 - Bilingualism Associated With Delay in Dementia Onset and Loss of the Second Language Golnoush Akhlaghipour, MD
05:30 PM - 06:30 PM	Abstract	10-005 - Network Analysis of Verbal Fluency in Individuals with Incident Cognitive Impairment
05:30 PM - 06:30 PM	Abstract	10-006 - Motoric Cognitive Risk Syndrome and Incident Dementia: Results from a Population-Based Prospective and Observational Cohort Study Harmehr Sekhon
05:30 PM - 06:30 PM	Abstract	10-007 - Masupirdine (SUVN-502), a 5-HT6 receptor antagonist in combination with Donepezil and Memantine in moderate Alzheimer's patients Ramakrishna Nirogi, PhD
05:30 PM - 06:30 PM	Abstract	10-008 - BAN2401 In Early Alzheimer's Disease: A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month Study With An Open-Label Extension Phase To Confirm Safety And Efficacy Shau Yu Lynch
05:30 PM - 06:30 PM	Abstract	10-009 - COR388 for the Treatment of Alzheimer's Disease
05:30 PM - 06:30 PM	Abstract	10-010 - Tele-Mindfulness for Dementia's Family Caregivers
05:30 PM - 06:30 PM	Abstract	10-011 - Thirty-six-month amyloid positron emission tomography results show continued reduction in amyloid burden with gantenerumab Gregory Klein, PhD
05:30 PM - 06:30 PM	Abstract	10-012 - Machine Learning Models Can Improve Efficiency of Alzheimer’s Disease Clinical Trials. Ali Ezzati, MD
05:30 PM - 06:30 PM	Abstract	4-001 - Ischemic Heart Disease and Decline in Cognitive Function in the First Year after Stroke Michael O'Sullivan, MD, PhD, FRACP
05:30 PM - 06:30 PM	Abstract	4-002 - A Stroke Survivor Pilot program is Feasible and Improves Patient Satisfaction
05:30 PM - 06:30 PM	Abstract	4-003 - Box Checking for Comprehensive Stroke Care Metrics of Depression Screening: Does it Actually Equate to Better Treatment Parneet K. Grewal, MD
05:30 PM - 06:30 PM	Abstract	4-004 - Antidepressant Use for Improving Functional Ischemic Stroke Outcomes Stephanie Kazi
05:30 PM - 06:30 PM	Abstract	4-005 - Unplanned Interruption of Acute Rehabilitation after Stroke Amanda A. Herrmann, PhD
05:30 PM - 06:30 PM	Abstract	4-006 - When Are You Going to Come Down? Impact of Substance Use Disorder on Stroke Outcomes Jessica D. Lee, MD, FAAN
05:30 PM - 06:30 PM	Abstract	4-007 - Safety and Efficacy of Percutaneous Transluminal Angioplasty for Atherosclerotic Stenosis of Vertebral Artery Origin Roman Herzig, MD, PhD
05:30 PM - 06:30 PM	Abstract	4-008 - Symptomatic Intracranial Hemorrhage after Basilar Artery Occlusion Thrombectomies Paige Banyas, DO
05:30 PM - 06:30 PM	Abstract	4-009 - Posterior Circulation Collaterals and Outcomes in Acute Basilar Occlusion Neethu Gopal, MBBS
05:30 PM - 06:30 PM	Abstract	4-010 - Stroke and Death Rate in Patient Cohort Studies of Extracranial Vertebral Artery Stenosis: A Systematic Review Ahmer Asif, MD
05:30 PM - 06:30 PM	Abstract	4-011 - Acute Obstructive Hydrocephalus and Ischemic Stroke as the Complications of Vertebrobasilar Dolichoectasia: A Case Report Jie Pan, MD
05:30 PM - 06:30 PM	Abstract	4-012 - The prevalence of albuminuria in patients diagnosed with acute hemorrhagic and ischemic stroke - a prospective cohort study from a single stroke center Annie L. Hsieh, MD, PhD
05:30 PM - 06:30 PM	Abstract	4-013 - Appropriate Management for a Patient of Moyamoya Disease Presenting with Ischemic Stroke as an Initial Manifestation in the First Trimester of Pregnancy and Good Clinical Course: a Case Report Masashi Watanabe, MD
05:30 PM - 06:30 PM	Abstract	4-014 - Poor Risk Factor Control And Lower Levels Of Physical Activity Predict Incident Major Cardiovascular Events In Patients With Symptomatic Vertebrobasilar Disease: A Post-hoc Analysis Of The SAMMPRIS Trial Leah Croll, MD
05:30 PM - 06:30 PM	Abstract	4-015 - The combined presence of hypertension and vitamin D deficiency increased the probability of the occurrence of small vessel disease in China Junliang Yuan, Sr., MD
05:30 PM - 06:30 PM	Abstract	4-016 - Stem cell therapy modulates inflammasome signaling in stroke: Possible involvement of Mitochondria? Pallab Bhattacharya, PhD
05:30 PM - 06:30 PM	Abstract	4-017 - Long-term Clinical Neurological Outcome and Predictors of Outcome following Arterial Ischemic Stroke of Childhood Tatia Aprasidze
05:30 PM - 06:30 PM	Abstract	4-018 - Progressive Ischemic Strokes With Malignant Cerebral Edema In a Patient With Concomitant Varicella Zoster Virus(VZV)Vasculopathy And Giant Cell Arteritis(GCA) Shilpa Haldal, MD
05:30 PM - 06:30 PM	Abstract	13-001 - Subarachnoid Hemorrhage Early Brain Edema Score is Associated with Shunt Dependence and Worse Clinical Outcomes Syeda Dania Shujaat, MD, MBBS
05:30 PM - 06:30 PM	Abstract	13-002 - Revisiting the Hunt Hess Scale: Evaluation after EVD placement better predicts mortality
05:30 PM - 06:30 PM	Abstract	13-003 - Moyomoya Syndrome Related to Right Middle Cerebral Artery Aneurysm Stent Occlusion Causing Subarachnoid Hemorrhage Pranusha Pinna, DO
05:30 PM - 06:30 PM	Abstract	13-004 - Assessing efficacy of four factor prothrombin complex concentrate (4FPCC) for reversal of direct factor Xa inhibitors in intracranial hemorrhages at an academic medical center
05:30 PM - 06:30 PM	Abstract	13-005 - Recovery after Hemorrhagic Stroke: the Power of Family Presence at the Bedside
05:30 PM - 06:30 PM	Abstract	13-006 - Non-Traumatic Subdural Hemorrhage and Risk of Arterial Ischemic Events Melvin Parasram, DO
05:30 PM - 06:30 PM	Abstract	13-007 - Posterior Reversible Encephalopathy Syndrome after transplantation Franco E. Appiani, MD
05:30 PM - 06:30 PM	Abstract	13-008 - Radiographic Distribution of Spinal Cord Segment Involvement Seen in Posterior Reversible Encephalopathy Syndrome with Spinal Cord Involvement. William J. Scharpf, DO
05:30 PM - 06:30 PM	Abstract	13-009 - Hot Off the PRES: A Case Series on Posterior Reversible Encephalopathy Syndrome with Hemorrhagic Conversion Associated with Phenylephrine Areesha Ahmed, MD
05:30 PM - 06:30 PM	Abstract	13-010 - Broken Heart, Broken Mind: Posterior Reversible Encephalopathy Syndrome and Takotsubo Cardiomyopathy in the Neuro ICU Yasmin Aghajan, MD
05:30 PM - 06:30 PM	Abstract	13-011 - Difficult Brain Death Examination After Undetermined Toxic Ingestion Danielle B. Cross, MD
05:30 PM - 06:30 PM	Abstract	13-012 - Retrospective Chart Review on Declaration of Brain Death across a Hospital System Stacey A. Williamson, MD
05:30 PM - 06:30 PM	Abstract	13-013 - Advanced Diffusion Kurtosis Imaging Improves Arousal Recovery Prediction in Comatose Survivors of Cardiac Arrest Matthew N. Jaffa, DO
05:30 PM - 06:30 PM	Abstract	13-014 - Functional Outcome of Post Cardiac Arrest Patients Who Underwent Therapeutic Hypothermia Julian Agin-Liebes, MD
05:30 PM - 06:30 PM	Abstract	13-015 - Pilot Study of Orexin as an Indicator of Coma Recovery Aileen Cangiano-Heath, MD
05:30 PM - 06:30 PM	Abstract	13-016 - Acute fulminant cerebral edema: a profile of 5 pediatric cases from a tertiary care center. Carlyn Patterson Gentile, MD
05:30 PM - 06:30 PM	Abstract	13-017 - Predictors of Withdrawal of Life Sustaining Treatments in ECMO Patients Julia Carlson, MD
05:30 PM - 06:30 PM	Abstract	13-018 - Paraparesis after extracorporeal membrane oxygenation: A report of two cases and review of literature Niloofar Yari, MD
05:30 PM - 06:30 PM	Abstract	5-001 - Standardization of Evaluation for Seizures During Therapeutic Hypothermia (TH) in Neonates with Hypoxic Ischemic Encephalopathy (HIE): A Quality Improvement (QI) Initiative Justin Rosati, MD
05:30 PM - 06:30 PM	Abstract	5-002 - Combined Conventional and Amplitude-Integrated EEG Monitoring in Neonates: A Prospective Study Sarah Grace Buttle, MD
05:30 PM - 06:30 PM	Abstract	5-003 - The Use of Midazolam for Refractory Neonatal Seizures Matthew Martin, MD
05:30 PM - 06:30 PM	Abstract	5-004 - Impact of recurrent seizures on white matter in non-structural neonatal epilepsy Amanda Sandoval Karamian, MD
05:30 PM - 06:30 PM	Abstract	5-005 - Improving Bedside Seizure Care of Pediatric Epilepsy Monitoring Unit (EMU) Patients: Creation and Implementation of a Standardized Protocol Sara Pavitt, MD
05:30 PM - 06:30 PM	Abstract	5-006 - Patterns of Disease and Predictors of Severity in Rasmussen's Encephalitis- a Retrospective Series of Thirty-Nine Cases Rohit Benjamin, MD, DM
05:30 PM - 06:30 PM	Abstract	5-007 - Management practices for West syndrome in South Asia Priyanka Madaan
05:30 PM - 06:30 PM	Abstract	5-008 - Keep Off the Grass: Artisanal versus Pharmaceutical Cannabidiol in Pediatric Refractory Epilepsy Patients Nathan T. Cohen, MD
05:30 PM - 06:30 PM	Abstract	5-009 - iPSC-generated motor neurons from patients with PTEN deficiency as a model to elucidate mechanisms underlying aberrant circuit development in autism spectrum disorder Michelle Allen-sharpley, MD, PhD
05:30 PM - 06:30 PM	Abstract	5-010 - An Online Survey of Caregivers of Patients with SCN8A-related epilepsy Celene Grayson, PhD
05:30 PM - 06:30 PM	Abstract	5-011 - Non-Syndromic Autistic Spectral Disorders in Tamilian Chldren Commonly Associated with Brain imaging anomalies and Spectral EEG changes Sunil K. Narayan, MD, FAAN
05:30 PM - 06:30 PM	Abstract	5-012 - Psychogenic Nonepileptic Events in Pediatric Patients with Autism Daniel Freedman, DO
05:30 PM - 06:30 PM	Abstract	5-013 - Utility of Video EEG (VEEG) in the Assessment of Staring Spells (SS) in Children with Autism
05:30 PM - 06:30 PM	Abstract	5-014 - Prescribing Practices and Antiepileptic Drug Choice in Benign Epilepsy with Centrotemporal Spikes Mariam Hull, MD
05:30 PM - 06:30 PM	Abstract	5-015 - The Phenotypic Spectrum of Epilepsy in Desanto-Shinawi Syndrome Abdulla Alawadhi, MBBS

Faculty Disclosures
Guido J. Falcone, MD	The institution of Dr. Falcone has received research support from NIH. The institution of Dr. Falcone has received research support from AHA.
Mario F. Mendez, MD, PhD, FAAN	Dr. Mendez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medical ��ɫ�� Speakers' Bureau. Dr. Mendez has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Mendez has received research support from NIH. Dr. Mendez has received publishing royalties from a publication relating to health care.
Neha Dangayach, MD, FAAN	Dr. Dangayach has nothing to disclose.
Mered Parnes, MD	Dr. Parnes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Pharmaceuticals. Dr. Parnes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Pharmaceuticals. The institution of Dr. Parnes has received research support from NIH. The institution of Dr. Parnes has received research support from Alexion.
Brian J. Hanrahan, MD	Dr. Hanrahan has received personal compensation for serving as an employee of Nowyouknow Neuro.
Shadi Yaghi, MD	Dr. Yaghi has nothing to disclose.
Namita Goyal, MD, FAAN	Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Souffle. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Goyal has received research support from Fulcrum. The institution of Dr. Goyal has received research support from Healey Platform. The institution of Dr. Goyal has received research support from Medicinova. The institution of Dr. Goyal has received research support from Transposon. The institution of Dr. Goyal has received research support from Abcuro. The institution of Dr. Goyal has received research support from Calico. The institution of Dr. Goyal has received research support from Clene. The institution of Dr. Goyal has received research support from Janssen. The institution of Dr. Goyal has received research support from PepGen. The institution of Dr. Goyal has received research support from PTC. The institution of Dr. Goyal has received research support from Roche. The institution of Dr. Goyal has received research support from Sanofi. The institution of Dr. Goyal has received research support from Prilenia. The institution of Dr. Goyal has received research support from RAPA. The institution of Dr. Goyal has received research support from Avidity. Dr. Goyal has received publishing royalties from a publication relating to health care.
Ericka P. Greene, MD, FAAN	Dr. Greene has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis . Dr. Greene has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN. Dr. Greene has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Abraham & Watkins Texas Law Firm. The institution of Dr. Greene has received research support from National Science Foundaton .
Suzanne Powell, MD	Dr. Powell has nothing to disclose.
Diego Torres-Russotto, MD, FAAN	Dr. Torres-Russotto has received personal compensation for serving as an employee of Movement Disorders Consulting, Inc. The institution of Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. The institution of Dr. Torres-Russotto has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. The institution of Dr. Torres-Russotto has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Revance. The institution of Dr. Torres-Russotto has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Anneal. Dr. Torres-Russotto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for IPSEN. Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. The institution of Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Torres-Russotto has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Your Nest Asset Solutions, LLC. Dr. Torres-Russotto has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Bright Future Asset Solutions, LLC.
Tahseen Mozaffar, MD, FAAN	Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amicus. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astellas Gene Therapy. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics. The institution of Dr. Mozaffar has received research support from NIH. The institution of Dr. Mozaffar has received research support from Muscular Dystrophy Association. The institution of Dr. Mozaffar has received research support from Sanofi. The institution of Dr. Mozaffar has received research support from Argenx. The institution of Dr. Mozaffar has received research support from Amicus Therapeutics. The institution of Dr. Mozaffar has received research support from Astellas Gene Therpay. The institution of Dr. Mozaffar has received research support from Cartesian. The institution of Dr. Mozaffar has received research support from Cabaletta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH.
Richard Webster	No disclosure on file
Julia Waskoenig, MD	No disclosure on file
Daniel Weintraub	Daniel Weintraub has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clintrex. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scion. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion. Daniel Weintraub has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Modality.ai. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CuraSen. Daniel Weintraub has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Daniel Weintraub has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorder Society. The institution of Daniel Weintraub has received research support from NIH. The institution of Daniel Weintraub has received research support from Fox Foundation. The institution of Daniel Weintraub has received research support from IPMDS. Daniel Weintraub has received intellectual property interests from a discovery or technology relating to health care.
Brij M. Ahluwalia-Singh, MD, FAAN	No disclosure on file
Leslie M. Shaw, PhD	Dr. Shaw has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Shaw has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Shaw has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Shaw has received research support from NIA. The institution of Dr. Shaw has received research support from MJ Fox foundation for Parkinsons Research.
Ashhar Ali, DO, FAAN	Dr. Ali has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Ali has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Ebsco.
Scott L. Silliman, MD	Dr. Silliman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Aksel Siva, MD	Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ali Raif Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanovel Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abdi Ibrahim Ilac - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono . The institution of Dr. Siva has received research support from Turkish MS Society. The institution of Dr. Siva has received research support from The Scientific and Technological Research Council Of Turkey - Health Sciences Research Grants.
Hans-Peter Hartung, MD, FAAN	Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Steven A. Greenberg, MD	Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abcuro, Inc.. Dr. Greenberg has stock in Abcuro. Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care.
Michael O'Sullivan, MD, PhD, FRACP	Prof. O'Sullivan has nothing to disclose.
Armistead Williams III, MD	Dr. Williams has nothing to disclose.
Murray Grossman, MD, FAAN	Dr. Grossman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Grossman has received research support from NIH.
John M. Bertoni, MD, PhD, FAAN	Dr. Bertoni has nothing to disclose.
Carolina Ionete, MD	Dr. Ionete has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Ionete has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Zenas. Dr. Ionete has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Ionete has received research support from Genetech. The institution of Dr. Ionete has received research support from NIH.
Jane Boggs, MD	The institution of Dr. Boggs has received research support from Liva Nova. Dr. Boggs has a non-compensated relationship as a Chairman PAB with Epilepsy Alliance North Carolina that is relevant to AAN interests or activities.
Erick Sell, MD	Dr. Sell has nothing to disclose.
Machteld E. Hillen, MD, FAAN	The institution of Dr. Hillen has received research support from Genentech.
	No disclosure on file
Tamara Miller, MD	Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics Therapeutics, Abbvie, Genentech. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono, TG Therapeutics, Biogen, Abbvie, Genentech, Lundbeck. The institution of Dr. Miller has received research support from Abbvie, Ipsen, Alexion, Pfizer, BMS, Genentech, ThermoFisher Scientific.
Dronacharya Lamichhane, MD	No disclosure on file
Irene Malaty, MD, FAAN	Dr. Malaty has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aevum. The institution of Dr. Malaty has received research support from Abbvie. The institution of Dr. Malaty has received research support from Revance. The institution of Dr. Malaty has received research support from Parkinson Foundation. The institution of Dr. Malaty has received research support from SAGE. The institution of Dr. Malaty has received research support from Emalex. The institution of Dr. Malaty has received research support from Acadia. Dr. Malaty has received publishing royalties from a publication relating to health care. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a Speaker & Center of Excellence Director with Parkinson Foundation. Dr. Malaty has a non-compensated relationship as a MAB member & Center of Excellence Directory with Tourette Association of America that is relevant to AAN interests or activities.
Robert G. Wilson, DO	Dr. Wilson has nothing to disclose.
Alejandro R. Marfil-Rivera, MD	Dr. Marfil-Rivera has nothing to disclose.
Leo H. Wang, MD, PhD, FAAN	Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AskBio. Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Fulcrum Therapeutics. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Wang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Wang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Avidity. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lupin. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. The institution of Dr. Wang has received research support from National Institute of Health. Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with US Government.
Matthew N. Jaffa, DO	Dr. Jaffa has nothing to disclose.
Ava Y. Lin, MD	No disclosure on file
Paulo P. Fontoura, MD, PhD, FAAN	Dr. Fontoura has received personal compensation for serving as an employee of F. Hoffmann La Roche. Dr. Fontoura has stock in Roche Pharmaceuticals.
Gunjan Parikh, MD	The institution of Dr. Parikh has received research support from Department of Defense. The institution of Dr. Parikh has received research support from NINDS. The institution of Dr. Parikh has received research support from NIH.
John Liang, MD	Dr. Liang has nothing to disclose.
Sandhya Ravikumar, MD	Dr. Ravikumar has nothing to disclose.
Joseph Legacy, MD	No disclosure on file
Kapil Arya, MBBS, DA, FAAP, FACNS, FAAN	Dr. Arya has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Arya has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Arya has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scholar Rock.
Martin Valis, MD	Dr. Valis has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Valis has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Valis has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva.
Brian Berman, MD, MS, FAAN	The institution of Dr. Berman has received research support from Dystonia Medical Research Foundation. The institution of Dr. Berman has received research support from National Institutes of Health. The institution of Dr. Berman has received research support from Neurocrine Biosciences. The institution of Dr. Berman has received research support from Benign Essential Blepharospasm Research Foundation. The institution of Dr. Berman has received research support from National Institutes of Health.
Oldrich Vysata	No disclosure on file
Mikael Cohen	Mikael Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Roche, Merck, Ad scientiam, Novartis, Alexion, BMS.
Melissa M. Cortez, DO	The institution of Dr. Cortez has received research support from NIH NINDS. The institution of Dr. Cortez has received research support from Dysautonomia International. Dr. Cortez has received personal compensation in the range of $500-$4,999 for serving as a Content Expert, Reviewer, DSMB with NIH RECOVER project.
Erin M. Feinstein, DO	Dr. Feinstein has nothing to disclose.
Ernesto Aycardi, MD	Dr. Aycardi has received personal compensation for serving as an employee of XENON. Dr. Aycardi has received stock or an ownership interest from XENON.
Sarah R. Durica, MD	An immediate family member of Dr. Durica has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with Federal Aviation Administration.
Harry H. Hill, MD	No disclosure on file
Stephanie Chen, MD	No disclosure on file
Ilana Spokoyny, MD	Dr. Spokoyny has nothing to disclose.
Wissam G. Deeb, MD, FAAN	Dr. Deeb has a non-compensated relationship as a Board member with Davis Phinney Foundation that is relevant to AAN interests or activities.
Ugur Uygunoglu	Ugur Uygunoglu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Turkey . The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen Idec/Gen Pharma of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck-Serono of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanovel of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Genveon of Turkey.
Gregory Klein, PhD	Dr. Klein has received personal compensation for serving as an employee of Roche. Dr. Klein has received stock or an ownership interest from Roche.
Alexandra S. Reynolds, MD	Dr. Reynolds has nothing to disclose.
Thomas D. Steeves, MD	No disclosure on file
Joan A. Conry, MD	No disclosure on file
Mai Nguyen, PhD	No disclosure on file
Suman Kushwaha, MD	Dr. Kushwaha has nothing to disclose.
Luis Fernandez	No disclosure on file
Gema E. Giler, MD	No disclosure on file
Sonika Agarwal, MD, FAAN	Dr. Agarwal has nothing to disclose.
Rula Hajj-Ali, MD	Rula Hajj-Ali, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Rula Hajj-Ali, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zena. Rula Hajj-Ali, MD has received publishing royalties from a publication relating to health care.
Barney J. Stern, MD, FAAN	Dr. Stern has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Foundation for Sarcoidosis Research. The institution of Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Stern has received research support from NIH/NINDS. The institution of Dr. Stern has received research support from NIH/NINDS. The institution of Dr. Stern has received research support from NIH/NINDS. The institution of Dr. Stern has received research support from NIH/NINDS. Dr. Stern has received publishing royalties from a publication relating to health care.
Daniel L. Labovitz, MD	An immediate family member of Dr. Labovitz has received personal compensation for serving as an employee of Herrick Feinstein.
Lauren Koffman, DO, MS	Dr. Koffman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Law Firm. Dr. Koffman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Walters Kluwer.
Aaron M. Carlson, MD	Dr. Carlson has received research support from Horizon Therapeutics (Amgen).
Jonathan R. Galli, MD	Dr. Galli has nothing to disclose.
Carlos A. Pardo-Villamizar, MD	The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research .
Marcus D'Souza, MD	Dr. D'Souza has nothing to disclose.
Teerin Liewluck, MD, FAAN	Dr. Liewluck has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics. Dr. Liewluck has received publishing royalties from a publication relating to health care.
Edward Avila, DO, FAAN	Dr. Avila has received publishing royalties from a publication relating to health care.
Ava L. Liberman, MD	Dr. Liberman has nothing to disclose.
Faddi G. Saleh Velez, MD	Dr. Saleh Velez has nothing to disclose.
Laurie J. Ozelius, PhD	The institution of Dr. Ozelius has received research support from NIH. Dr. Ozelius has received intellectual property interests from a discovery or technology relating to health care.
Geoffrey A. Kerchner, MD, PhD	Dr. Kerchner has received personal compensation for serving as an employee of F. Hoffmann-La Roche, Ltd.. Dr. Kerchner has stock in F. Hoffmann-La Roche, Ltd.. Dr. Kerchner has received publishing royalties from a publication relating to health care.
Harald Hampel	Harald Hampel has received personal compensation for serving as an employee of Eisai Inc..
Jill M. Olson, MD	No disclosure on file
Murat Kurtuncu, MD	Dr. Kurtuncu has nothing to disclose.
Ahmad El Kouzi, MD, FAAN	Dr. El Kouzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie.
Ka-Ho Wong	The institution of Mr. Wong has received research support from The Sumaira Foundation . The institution of Mr. Wong has received research support from The Siegel Rare Neuroimmune Association.
Stacey Clardy, MD, PhD, FAAN	Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. The institution of Dr. Clardy has received research support from Kyverna. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Advent Health Florida, Beaumont Health, CCF, Emory, Penn State Health, Mayo Clinic, Walter Reed.
John W. Rose, MD, FAAN	The institution of Dr. Rose has received research support from National Multiple Sclerosis Society. The institution of Dr. Rose has received research support from Guthy Jackson Charitable Foundation. The institution of Dr. Rose has received research support from NIH . The institution of Dr. Rose has received research support from VA. The institution of Dr. Rose has received research support from Biogen. The institution of Dr. Rose has received research support from Friends of MS. Dr. Rose has received intellectual property interests from a discovery or technology relating to health care.
Justin Y. Kwan, MD, FAAN	Dr. Kwan has received research support from National Institutes of Health. Dr. Kwan has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with National Institutes of Health.
Conrad Weihl, MD, PhD	Dr. Weihl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Weihl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Casma therapeutics. Dr. Weihl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abata. Dr. Weihl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Weihl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Weihl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acceleron. Dr. Weihl has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Wilson Elser Moskowitz Edelman & Dicker LLP.
Devashish D. Ruikar, MD	Dr. Ruikar has nothing to disclose.
James F. Meschia, MD, FAAN	The institution of Dr. Meschia has received research support from NINDS. The institution of Dr. Meschia has received research support from NINDS.
John E. Greenlee, MD, FAAN	Dr. Greenlee has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink. Dr. Greenlee has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Zeigler Cohen Roche. Dr. Greenlee has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Sommers Schwartz PC. Dr. Greenlee has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for St Francis Hospital. Dr. Greenlee has received publishing royalties from a publication relating to health care. Dr. Greenlee has received publishing royalties from a publication relating to health care.
Michelle P. Lin, CRC	Dr. Lin has nothing to disclose.
Sabahattin Saip	Sabahattin Saip has nothing to disclose.
Ahmad Al-Awwad, MD	Dr. Al-Awwad has nothing to disclose.
Richard B. Lipton, MD, FAAN	Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Stephen Thein, PhD	No disclosure on file
Kenichiro Taira, MD, PhD	Dr. Taira has nothing to disclose.
Amanda L. Piquet, MD, FAAN	The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyverna . The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech/Roche. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Sands Anderson PC. Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Joe Jones Law Firm. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Cortez & Associates. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Falk Waas. The institution of Dr. Piquet has received research support from Rocky Mountain MS Center. The institution of Dr. Piquet has received research support from Roche/Genentech. The institution of Dr. Piquet has received research support from NYU. The institution of Dr. Piquet has received research support from Anokion. The institution of Dr. Piquet has received research support from UCB . The institution of Dr. Piquet has received research support from Foundation for Sarcoidosis. The institution of Dr. Piquet has received research support from Kyverna . Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Litigative Consultant with US-Dept HHS/DICP. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Autoimmune Encephalitis Alliance (AEA) that is relevant to AAN interests or activities. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Stiff Person Syndrome Research Foundation (SPSRF) that is relevant to AAN interests or activities.
Adil Javed, MD, PhD	The institution of Dr. Javed has received research support from Genentech Roche .
Margherita Milone, MD, FAAN	Dr. Milone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian Therapeutics. Dr. Milone has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics, AAN. The institution of Dr. Milone has received research support from Mayo Clinic, CCaTS-CBD. The institution of Dr. Milone has received research support from Mayo Clinic, SGP Award. The institution of Dr. Milone has received research support from MDA for Care Center grant. The institution of Dr. Milone has received research support from Regenerative medicine Minnesota.
Gil Midroni, MD	No disclosure on file
Karl Alstadhaug, MD, PhD	No disclosure on file
Jorge G. Ortiz-Garcia, MD, FAAN	Dr. Ortiz-Garcia has nothing to disclose.
Ichizo Nishino, MD, PhD, FAAN	The institution of Dr. Nishino has received research support from AMED.
Cecilia Serrano	No disclosure on file
James P. Valeriano, MD	Dr. Valeriano has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for ucb. Dr. Valeriano has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for neurilis.
Jinny O. Tavee, MD	Dr. Tavee has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL Behring. Dr. Tavee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. Tavee has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. The institution of Dr. Tavee has received research support from Woolsey. The institution of Dr. Tavee has received research support from Milken Foundation. The institution of Dr. Tavee has received research support from CSL Behring. Dr. Tavee has received personal compensation in the range of $0-$499 for serving as a Article author with Medlink.
Masashi Watanabe, MD	Dr. Watanabe has nothing to disclose.
Virginia Baker, MD	Dr. Baker has nothing to disclose.
Ashutosh P. Jadhav, MD, FAAN	Dr. Jadhav has nothing to disclose.
Hamza I. Maqsood, MD	Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Madoka Mori-Yoshimura, MD, PhD	Dr. Mori-Yoshimura has nothing to disclose.
Shivika Chandra, MD, FAAN	The institution of Dr. Chandra has received research support from American Board of Psychiatry and Neurology Faculty Innovation in ��ɫ�� Award. The institution of Dr. Chandra has received research support from Michael J Fox Foundation.
Shamik Bhattacharyya, MD, FAAN	Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroLambda. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum. Dr. Bhattacharyya has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. Dr. Bhattacharyya has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Merck. The institution of Dr. Bhattacharyya has received research support from Alexion Pharmaceuticals. The institution of Dr. Bhattacharyya has received research support from National Institute of Health. The institution of Dr. Bhattacharyya has received research support from UCB. The institution of Dr. Bhattacharyya has received research support from Genentech. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care.
Ira J. Goodman, MD	No disclosure on file
Brant Oliver	Brant Oliver has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for @ Point of Care. The institution of Brant Oliver has received research support from Biogen.
Sheetal Shroff, MD	Dr. Shroff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Shroff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Dr. Shroff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Shroff has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astra Zeneca. Dr. Shroff has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Shroff has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.
Veronica P. Cipriani, MD, FAAN	Dr. Cipriani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Cipriani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Cipriani has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Pharmaceuticals. Dr. Cipriani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Cipriani has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Cipriani has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Cipriani has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Cipriani has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Cipriani has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Cipriani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with Vaccine Injury Compensation Program. Dr. Cipriani has received personal compensation in the range of $500-$4,999 for serving as a Member of Board of Directors with Chicago MS Alliance.
Pranusha Pinna, DO	Dr. Pinna has nothing to disclose.
Niloofar Yari, MD	Dr. Yari has nothing to disclose.
Duriel I. Hardy, MD	Dr. Hardy has nothing to disclose.
Tammy L. Smith, MD, PhD	Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. Smith has received research support from Alexion/AstraZeneca.
Scott D. Newsome, DO, FAAN	Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Newsome has received research support from Biogen. The institution of Dr. Newsome has received research support from Genentech/Roche. The institution of Dr. Newsome has received research support from Department of Defense. The institution of Dr. Newsome has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Newsome has received research support from National MS Society. The institution of Dr. Newsome has received research support from Lundbeck. The institution of Dr. Newsome has received research support from Sanofi. The institution of Dr. Newsome has received research support from Kyverna Therapeutics. Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving as a Lead PI for Clinical Trial with Roche.
Sunil K. Narayan, MD, FAAN	The institution of Dr. Narayan has received research support from Indian Council of Medical Research, Ministry of Health and Family Welfare, Government of India. The institution of Dr. Narayan has received research support from Department of Biotechnlogy, Ministry of Science and Technology, Government of India. The institution of Dr. Narayan has received research support from DST-(SERB). The institution of Dr. Narayan has received research support from Ms.Gurutva Medical Technology, India. Dr. Narayan has received intellectual property interests from a discovery or technology relating to health care. Dr. Narayan has received intellectual property interests from a discovery or technology relating to health care. Dr. Narayan has received personal compensation in the range of $0-$499 for serving as a Intermediate Grants, Evaluation Expert committee Member with Department of Health Research, Government of India.
Vince Tran	No disclosure on file
Shiv Saidha, MD	Dr. Saidha has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Setpoint Medical. Dr. Saidha has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Saidha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ReWind Therapeutics. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Pharmaceuticals. Dr. Saidha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Saidha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Saidha has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Multiple Sclerosis Journal ETC. Dr. Saidha has stock in June Brain. Dr. Saidha has stock in Lapix Therapeutics. The institution of Dr. Saidha has received research support from Biogen. The institution of Dr. Saidha has received research support from Genentech. The institution of Dr. Saidha has received research support from Novartis. The institution of Dr. Saidha has received research support from Lapix Therapeutics. The institution of Dr. Saidha has received research support from Novartis.
Jerry Prince	No disclosure on file
Tuncay Gunduz, MD	The institution of Dr. Gunduz has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Pharmaceuticals. Dr. Gunduz has received research support from Turkish Neuroimmunology Society.
Matthew R. Burns, MD, PhD	The institution of Dr. Burns has received research support from NIH. The institution of Dr. Burns has received research support from Mcknight Brain Institute.
Samantha K. Holden, MD, MS, FAAN	The institution of Dr. Holden has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics.
Boulenouar Mesraoua, MD, FAAN	Dr. Mesraoua has nothing to disclose.
Michael C. Irizarry, MD	Dr. Irizarry has received personal compensation for serving as an employee of Eisai, Inc..
Jessica D. Lee, MD, FAAN	Dr. Lee has received personal compensation for serving as an employee of ��ɫ��. The institution of Dr. Lee has received research support from Janssen.
Gilles Allali, MD, PhD	Dr. Allali has nothing to disclose.
Augusto A. Miravalle, MD, FAAN	Dr. Miravalle has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BMS. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG therapeutics. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Miravalle has received research support from Genzyme. The institution of Dr. Miravalle has received research support from EMD Serono. The institution of Dr. Miravalle has received research support from Alexion.
Lynn D. Kramer, MD, FAAN	Dr. Kramer has received personal compensation for serving as an employee of Eisai Inc. Dr. Kramer has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Eisai Co., Ltd..
Victor Chan, MD	No disclosure on file
Roman Herzig, MD, PhD	Roman Herzig, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Roman Herzig, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boehringer Ingelheim . Roman Herzig, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Care Comm.
Maria Kristina C. Dorotan, MD	Dr. Dorotan has nothing to disclose.
David Laplaud	No disclosure on file
Xandra O. Breakefield, PhD	Dr. Breakefield has nothing to disclose.
Tanya Bogoslovsky, MD, FAAN	Dr. Bogoslovsky has received personal compensation for serving as an employee of Eisai Inc.
Jonathan Cauchi, MD	Dr. Cauchi has nothing to disclose.
Alissa Rothman	No disclosure on file
Julian Martinez Agosto, MD, PhD	Julian Martinez Agosto, MD, PhD has nothing to disclose.
Esther Cubo Delgado, MD, PhD, FAAN	Dr. Cubo Delgado has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Cubo Delgado has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Zambon. Dr. Cubo Delgado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Cubo Delgado has received research support from Spanish health ministry. The institution of Dr. Cubo Delgado has received research support from European union grant.
Haitham Hussein, MD, FAAN	Dr. Hussein has nothing to disclose.
Tara A. Kimbrough, MD	Dr. Kimbrough has nothing to disclose.
Nicole M. Warner, ARNP	No disclosure on file
Tirisham Gyang, MD	Dr. Gyang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono.
Teesta B. Soman, MD, MBBS	No disclosure on file
Michael J. Doherty, MD, FAAN	No disclosure on file
Juan F. Gongora Rivera, MD, MD, MSc, PhD	Dr. Gongora Rivera has nothing to disclose.
Thy Nguyen, MD	Dr. Nguyen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for ArgenX. Dr. Nguyen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Nguyen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Nguyen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Nguyen has received publishing royalties from a publication relating to health care.
Ali Ezzati, MD	The institution of Dr. Ezzati has received research support from NIA. The institution of Dr. Ezzati has received research support from Alzheimer's Association. The institution of Dr. Ezzati has received research support from Cure Alzheimer's Fund.
Omar Saeed, MD	Dr. Saeed has nothing to disclose.
Bappaditya Ray, MD	Dr. Ray has nothing to disclose.
Elie Naddaf, MD	Dr. Naddaf has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Expert Connect. Dr. Naddaf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Klick, Inc. Dr. Naddaf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WebMD. Dr. Naddaf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson and Johnson. Dr. Naddaf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arcellx. The institution of Dr. Naddaf has received research support from NIAMS. The institution of Dr. Naddaf has received research support from Fulcrum therapeutics. The institution of Dr. Naddaf has received research support from Abcuro. The institution of Dr. Naddaf has received research support from Cabaletta . The institution of Dr. Naddaf has received research support from Arcellx.
Masoom J. Desai, MD	Dr. Desai has nothing to disclose.
Toshiyuki Yamamoto	Dr. Yamamoto has nothing to disclose.
James E. Eaton III, MD	Dr. Eaton has received personal compensation in the range of $0-$499 for serving as a Consultant for Uniqure. Dr. Eaton has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Law Practices. Dr. Eaton has received personal compensation in the range of $0-$499 for serving as a Speaker with Can Do MS.
Orrin Devinsky, MD, FAAN	Dr. Devinsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Devinsky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for California Cannabis Enterprises. Dr. Devinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Engage. Dr. Devinsky has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Privateer Holdings. Dr. Devinsky has received personal compensation in the range of $1,000,000+ for serving on a Scientific Advisory or Data Safety Monitoring board for Receptor Holdings. Dr. Devinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rettco. Dr. Devinsky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Silver Spike. Dr. Devinsky has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tevard. Dr. Devinsky has received personal compensation in the range of $1,000,000+ for serving on a Scientific Advisory or Data Safety Monitoring board for Tilray. Dr. Devinsky has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Engage. Dr. Devinsky has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Tevard Biosciences. Dr. Devinsky has stock in Engage. Dr. Devinsky has stock in Empatica. Dr. Devinsky has stock in California Cannabis Enterprises. Dr. Devinsky has stock in Empatica. Dr. Devinsky has stock in Silver Spike. Dr. Devinsky has stock in Docklight Brands. Dr. Devinsky has stock in Egg Rock/Papa Barkley. Dr. Devinsky has stock in Leafly. Dr. Devinsky has stock in Left Coast Ventures. Dr. Devinsky has stock in Privateer Holdings. Dr. Devinsky has stock in Receptor Holdings. Dr. Devinsky has stock in Qstate. The institution of Dr. Devinsky has received research support from GW Pharma. The institution of Dr. Devinsky has received research support from Zogenix. The institution of Dr. Devinsky has received research support from PTC Pharma. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from DOD. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from Epilepsy Foundation. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from NSF. Dr. Devinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Devinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Devinsky has received publishing royalties from a publication relating to health care.
Neal S. Parikh, MD	Dr. Parikh has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Dr. Parikh has or had stock in Alnylam Pharmaceuticals.
Daniel Blackburn, MD	No disclosure on file
Aaron Lord, MD	Dr. Lord has nothing to disclose.
Harpreet Kaur, MD	No disclosure on file
Niccolò Mencacci	No disclosure on file
Andrea Hildebrand	The institution of Ms. Hildebrand has received research support from National MS Society.
Mireya M. Bolo-Diaz, MD	No disclosure on file
Tej Mehta	No disclosure on file
Alexander Merkler, MD	Dr. Merkler has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Neurohospitalist. Dr. Merkler has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for n/a.
Raed Alroughani, MD, FAAN	Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, AstraZeneca, Novartis, Merck, Roche, Sanofi. Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AstraZeneca, Biogen, Novartis, Merck, Roche, Sanofi.
Jonathan Dissin, MD	Dr. Dissin has received stock or an ownership interest from GlaxoSmithKline. Dr. Dissin has received stock or an ownership interest from Abbvie.
Marius Ringelstein	Marius Ringelstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Marius Ringelstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Ken Myers, MD, PhD	Dr. Myers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Myers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Myers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pendopharm. Dr. Myers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AS2Bio. The institution of Dr. Myers has received research support from Fonds de Recherche de Santé Québec. The institution of Dr. Myers has received research support from Liam Foundation. The institution of Dr. Myers has received research support from Pediatric Research Foundation. The institution of Dr. Myers has received research support from Montreal Children's Hospital Foundation. The institution of Dr. Myers has received research support from CQDM/Pharma Liam. The institution of Dr. Myers has received research support from CIHR.
Krishna Nalleballe, MD, FAAN	Dr. Nalleballe has nothing to disclose.
Paul Wright, MD, FAAN	Dr. Wright has nothing to disclose.
Bade Gulec	Bade Gulec has nothing to disclose.
Mary T. Silvia, MD	Dr. Silvia has nothing to disclose.
Matthew C. Miles	Matthew C Miles has nothing to disclose.
Stacey A. Williamson, MD	Dr. Williamson has nothing to disclose.
Luis G. Manrique, MD	Dr. Manrique has nothing to disclose.
Samir Patel, MD, DNB, FEBN, MRCP, FRCP, FAAN	Dr. Patel has nothing to disclose.
Julian Agin-Liebes, MD	Dr. Agin-Liebes has nothing to disclose.
Melih Tutuncu, MD	Dr. Tutuncu has nothing to disclose.
Ashley E. Anderson, MD	Dr. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen/Johnson&Johnson. Dr. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen.
Michael Gliem, MD	No disclosure on file
Prasuna Kamireddi, MBBS	Dr. Kamireddi has nothing to disclose.
Toluwalase O. Tofade, MBBS	Dr. Tofade has nothing to disclose.
William J. Scharpf, DO	No disclosure on file
Catherine Stanecki, DO	Dr. Stanecki has nothing to disclose.
Thomas F. Tropea, DO	Dr. Tropea has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial. The institution of Dr. Tropea has received research support from NINDS. The institution of Dr. Tropea has received research support from Parkinson Foundation. The institution of Dr. Tropea has received research support from Michael J Fox Foundation.
Amy R. Harrison, MD	No disclosure on file
Jasem Y. Al-Hashel, MD	Dr. Al-Hashel has nothing to disclose.
Erwin Chiquete, MD, PhD	No disclosure on file
Hooman Kamel, MD	Dr. Kamel has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Kamel has received personal compensation in the range of $50,000-$99,999 for serving as a Endpoint adjudication committee with Boehringer-Ingelheim.
Kaitlin Reilly-Kit, MD	Dr. Reilly-Kit has nothing to disclose.
Jocelyn Montalvo, MD	Dr. Montalvo has nothing to disclose.
Roberto Cervantes Uribe, MD	No disclosure on file
Jesse M. Cedarbaum, MD, FAAN	No disclosure on file
Divyajot Sandhu, MD, MBBS	Dr. Sandhu has nothing to disclose.
Eda Turanli	The institution of Eda Turanli has received research support from Scientific and Technological Research Council of Turkey (TÜBITAK). The institution of Eda Turanli has received research support from Turkish MS Society. The institution of Eda Turanli has received research support from Acibadem University Scientific Research Projects Commission . The institution of Eda Turanli has received research support from Istanbul University Scientific Research Projects Commission .
Samuel Snider, MD	Dr. Snider has nothing to disclose.
Parneet K. Grewal, MD	The institution of Dr. Grewal has received research support from Bristol Myer Squibb Foundation. The institution of Dr. Grewal has received research support from IPSEN Global.
Rashid Kazerooni	Rashid Kazerooni has received personal compensation for serving as an employee of Merz Therapeutics.
Alexandra Montalvo Acevedo, MD	Dr. Montalvo Acevedo has nothing to disclose.
Melih Tutuncu, MD	No disclosure on file
Lynn Liu, MD, FAAN	Dr. Liu has nothing to disclose.
Robert C. Stowe, MD	Dr. Stowe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine Biosciences. Dr. Stowe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda Pharmaceuticals. Dr. Stowe has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Kherkher Garcia, LLP.
Jessica Gonzalez Montes, MD	No disclosure on file
Carla F. Bolano Diaz, MD	Dr. Bolano Diaz has nothing to disclose.
Sara Pavitt, MD	An immediate family member of Dr. Pavitt has received personal compensation for serving as an employee of NuvieBio. An immediate family member of Dr. Pavitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. The institution of Dr. Pavitt has received research support from PCORI.
Stephanie Kazi	No disclosure on file
Courtney Wusthoff, MD, FAAN	Dr. Wusthoff has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for ICON. Dr. Wusthoff has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Wusthoff has received research support from NIH. Dr. Wusthoff has received publishing royalties from a publication relating to health care.
Anat Mirelman	Anat Mirelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie . Anat Mirelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. The institution of Anat Mirelman has received research support from Department of Defense. The institution of Anat Mirelman has received research support from MJFF. The institution of Anat Mirelman has received research support from JPND. The institution of Anat Mirelman has received research support from EU-Horizon 2020.
Melvin Parasram, DO	Dr. Parasram has nothing to disclose.
Elif Everest, PhD	Ms. Everest has received personal compensation in the range of $50,000-$99,999 for serving as a postdoctoral visiting fellow with National Institutes of Health.
Christopher P. Kellner, MD	Dr. Kellner has stock in METIS Innovative. Dr. Kellner has stock in Precision Recovery. Dr. Kellner has stock in Synchron. Dr. Kellner has stock in Fluid BioMed. Dr. Kellner has stock in Proprio. Dr. Kellner has stock in Von Vascular. Dr. Kellner has stock in E8. Dr. Kellner has stock in Borvo. Dr. Kellner has stock in Phantom Neuro. Dr. Kellner has stock in Radical. Dr. Kellner has stock in Reach Neuro. Dr. Kellner has stock in Aurenar. The institution of Dr. Kellner has received research support from Integra. The institution of Dr. Kellner has received research support from Penumbra. The institution of Dr. Kellner has received research support from Viz.AI. The institution of Dr. Kellner has received research support from ICE Neurosystems. The institution of Dr. Kellner has received research support from Irras. The institution of Dr. Kellner has received research support from Microtransponder. The institution of Dr. Kellner has received research support from Medtronic. The institution of Dr. Kellner has received research support from Longeviti. The institution of Dr. Kellner has received research support from Endostream. The institution of Dr. Kellner has received research support from CVAID.
Yohei Harada, MD	Dr. Harada has nothing to disclose.
Blair Apple	No disclosure on file
Soumya Bouchachi, MD	Dr. Bouchachi has nothing to disclose.
Roy E. Strowd III, MD, FAAN	Dr. Strowd has received personal compensation for serving as an employee of Kaplan. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical, Inc. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. The institution of Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SpringWorks . Dr. Strowd has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. The institution of Dr. Strowd has received research support from Southeastern Brain Tumor Foundation. The institution of Dr. Strowd has received research support from Jazz Pharmaceuticals. The institution of Dr. Strowd has received research support from National Institutes of Health. The institution of Dr. Strowd has received research support from Alpha Omega Alpha. The institution of Dr. Strowd has received research support from American Board of Psychiatry and Neurology. Dr. Strowd has received publishing royalties from a publication relating to health care. Dr. Strowd has received publishing royalties from a publication relating to health care.
Seward B. Rutkove, MD, FAAN	Dr. Rutkove has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Myolex, Inc. Dr. Rutkove has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neuorlogy . The institution of Dr. Rutkove has received research support from NIH. The institution of Dr. Rutkove has received research support from NASA. The institution of Dr. Rutkove has received research support from Blavatnik Family Foundation. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NIH.
Andrew D. Siderowf, MD	Dr. Siderowf has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer-Ingelheim. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for askbio. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for capsida. Dr. Siderowf has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Parkinson Study Group. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theravance. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prilenia. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wave. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurogastrix. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prevail. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alerity. Dr. Siderowf has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Clintrex. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. Dr. Siderowf has a non-compensated relationship as a Scientific Advisory Board with NeuroPacs that is relevant to AAN interests or activities.
Richard J. Nowak, MD	Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Nowak has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio . Dr. Nowak has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cour Pharma. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janseen . The institution of Dr. Nowak has received research support from UCB. The institution of Dr. Nowak has received research support from Alexion . The institution of Dr. Nowak has received research support from Janseen. The institution of Dr. Nowak has received research support from Immunovant . The institution of Dr. Nowak has received research support from argenx. The institution of Dr. Nowak has received research support from Amgen. Dr. Nowak has a non-compensated relationship as a Member of the Board of Directors with Myasthenia Gravis Foundation of America (MGFA) that is relevant to AAN interests or activities.
Khondoker Alam, MD	No disclosure on file
Phong T. Vu, MD	Dr. Vu has nothing to disclose.
Jonathan Greco, DO	No disclosure on file
Danish Bhatti, MD, FAAN	Dr. Bhatti has nothing to disclose.
Dara V. Albert, DO, FAAN	Dr. Albert has nothing to disclose.
Amy Hellman, MD, FAAN	The institution of Dr. Hellman has received research support from COBRE-NIH. The institution of Dr. Hellman has received research support from Neurocrine.
Bhaskar Roy, MD, FAAN	Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Roy has or had stock in Cabaletta bio. .Dr. Roy has or had stock in Pfizer.Dr. Roy has or had stock in CAVA. The institution of Dr. Roy has received research support from Abcuro Pharmaceuticals. The institution of Dr. Roy has received research support from Immunovant. The institution of Dr. Roy has received research support from argenx.
Annie L. Hsieh, MD, PhD	An immediate family member of Dr. Hsieh has received personal compensation for serving as an employee of Pfizer.
Frank Diaz, MD, PhD	Dr. Diaz has nothing to disclose.
Sahara Cathcart, MD	No disclosure on file
Jithangi Wanigasinghe	No disclosure on file
Aarushi Suneja, MD	Dr. Suneja has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Suneja has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie.
Markus Reuber	No disclosure on file
Xavier Ayrignac	Xavier Ayrignac has nothing to disclose.
Brenda E. Porter, MD, PhD	An immediate family member of Dr. Porter has received personal compensation for serving as an employee of Sangamo. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taysha. An immediate family member of Dr. Porter has received stock or an ownership interest from Johnson and Johnson.
Aileen Cangiano-Heath, MD	Dr. Cangiano-Heath has nothing to disclose.
Alfredo Thomson, MD	Dr. Thomson has nothing to disclose.
Babak Navi, MD	Dr. Navi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Navi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MindRhythm Inc. Dr. Navi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for multiple medicolegal firms.
Tanya Gurevich, MD	Dr. Gurevich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medison, Abbvie, Teva, Neuroderm . Dr. Gurevich has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medison, Abbvie, Teva, Neuroderm, Truemed . Dr. Gurevich has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medison, Acino Ukraine, Abbvie. The institution of Dr. Gurevich has received research support from Parkinson's Disease and Movement disorders society .
Ricardo D. Bernater	No disclosure on file
Klepper Alfredo Garcia, MD	Dr. Garcia has nothing to disclose.
Debra Guntrum, MS, FNP	Ms. Guntrum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avexis. Ms. Guntrum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Ms. Guntrum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC.
Meir Kestenbaum, MD	No disclosure on file
Kevin N. Sheth, MD, FAAN	Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.
Annalena Venneri, PhD	No disclosure on file
Nir Giladi, MD, FAAN	Dr. Giladi has received personal compensation in the range of $0-$499 for serving as a Consultant for Sionara. Dr. Giladi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NeuroDerm. Dr. Giladi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pharma2B. Dr. Giladi has stock in Vibrant. Dr. Giladi has stock in Lysosomal Therapeutics . The institution of Dr. Giladi has received research support from The Michael J Fox Foundation. The institution of Dr. Giladi has received research support from The National Parkinson Foundation. The institution of Dr. Giladi has received research support from The European Union . The institution of Dr. Giladi has received research support from The Israel Science Foundation. The institution of Dr. Giladi has received research support from Biogen . The institution of Dr. Giladi has received research support from Ionis. The institution of Dr. Giladi has received research support from Sieratzki Family Foundation . The institution of Dr. Giladi has received research support from The Aufzien Academic Center in Tel-Aviv University.
Ladislav Pazdera, MD, FAAN	Dr. Pazdera has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Pazdera has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva.
Taskin Duman	Dr. Duman has nothing to disclose.
Mayela Marie Diaz Diaz, MD	No disclosure on file
Ondrej Dostal	The institution of Ondrej Dostal has received research support from Ministry of ��ɫ�� Youths and Sports.
Deepaneeta Sarmah, M Pharm	Miss Sarmah has nothing to disclose.
Clarisse Carra-Dalliere	No disclosure on file
Leah Croll, MD	Dr. Croll has nothing to disclose.
Marisel Vazquez, MD	Dr. Vazquez has nothing to disclose.
Franco E. Appiani, MD	Dr. Appiani has nothing to disclose.
Denis Vezina, PhD	No disclosure on file
Tatia Aprasidze	No disclosure on file
Andrew Mammen, MD, PhD	Dr. Mammen has received research support from National Institutes of Health. The institution of an immediate family member of Dr. Mammen has received research support from National Institutes of Health. Dr. Mammen has received intellectual property interests from a discovery or technology relating to health care.
Matthew D. Cykowski, MD	No disclosure on file
Dinesh V. Jillella, MD	Dr. Jillella has nothing to disclose.
Daniela Pohl	Daniela Pohl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos.
Kristine H. O'Phelan, MD	Dr. O'Phelan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bard Medical. Dr. O'Phelan has a non-compensated relationship as a DSMB member SIREN network with NIH/NINDS that is relevant to AAN interests or activities.
David Irwin, MD	The institution of Dr. Irwin has received research support from NIH. The institution of Dr. Irwin has received research support from Prevail. The institution of Dr. Irwin has received research support from Passage Bio. The institution of Dr. Irwin has received research support from Alector. The institution of Dr. Irwin has received research support from Transposon. The institution of Dr. Irwin has received research support from Denali. The institution of Dr. Irwin has received research support from Cervo Med.
Debbie Terry, NP	No disclosure on file
Orhan Aktas, MD	Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen/Horizon. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubish Tanake. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen/Horizon. The institution of Dr. Aktas has received research support from German Research Foundation. The institution of Dr. Aktas has received research support from German Ministry of Science. The institution of Dr. Aktas has received research support from Neuromyelitis optica Study Group (NEMOS).
Philipp Albrecht, PhD	Dr. Albrecht has received personal compensation for serving as an employee of Abbvie. Dr. Albrecht has received personal compensation for serving as an employee of Biogen. Dr. Albrecht has received personal compensation for serving as an employee of Bristol Myers Squibb. Dr. Albrecht has received personal compensation for serving as an employee of Ipsen. Dr. Albrecht has received personal compensation for serving as an employee of Merck. Dr. Albrecht has received personal compensation for serving as an employee of Merz. Dr. Albrecht has received personal compensation for serving as an employee of Novartis. Dr. Albrecht has received personal compensation for serving as an employee of Roche. Dr. Albrecht has received personal compensation for serving as an employee of Sanofi. Dr. Albrecht has received personal compensation for serving as an employee of Lilly.
Samar F. Ahmed, MD	Dr. Ahmed has nothing to disclose.
Sania Atta, MBBS	No disclosure on file
Rajanigandhi Hanumanthu, MD	No disclosure on file
Katya Rascovsky	No disclosure on file
Adil Iqbal, MD	No disclosure on file
Jyotika Singh	Ms. Singh has nothing to disclose.
Alison M. Fields, NP	No disclosure on file
Sumire Sato	No disclosure on file
Terri Milburn	Ms. Milburn has nothing to disclose.
Sarah Grace Buttle, MD	No disclosure on file
Tyler Irani, MD	Dr. Irani has nothing to disclose.
Matthew R. Ayers, DO	No disclosure on file
David G. Clark, MD	Dr. Clark has received publishing royalties from a publication relating to health care.
Shilpa Haldal, MD	Dr. Haldal has nothing to disclose.
Mitesh P. Lotia, MD	Dr. Lotia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Lotia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orphalan. Dr. Lotia has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbott.
James R. Couch, Jr., MD, PhD, FAAN	No disclosure on file
Edwin S. Vargas, MD	Dr. Vargas has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Dr. Vargas has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for CSL Berhing.
Pallab Bhattacharya, PhD	Dr. Bhattacharya has nothing to disclose.
Alejandro Thomson, MD	Dr. Thomson has nothing to disclose.
Yang Zheng, MD, PhD	Dr. Zheng has nothing to disclose.
Susan M. Fiore	No disclosure on file
Dileep R. Yavagal, MD, FAAN	Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vascular Dynamics. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. The institution of Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Medtronic. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus/Johnson & Johnson. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Poseydon. Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Athersys. Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gravity Medical Technology. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Poseydon. Dr. Yavagal has stock in Poseydon. Dr. Yavagal has stock in Galaxy Therapeutics. Dr. Yavagal has stock in Stentrode. Dr. Yavagal has stock in Gravity Medical. Dr. Yavagal has stock in Gravity Medical Technology. Dr. Yavagal has stock in Athersys. Dr. Yavagal has stock in Rapid Medical . Dr. Yavagal has received intellectual property interests from a discovery or technology relating to health care. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Expert with Royal Carribean Cruise Line. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Consultant with Carnival Cruise Line.
Avner Thaler, MD	The institution of Dr. Thaler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ABBVIE. The institution of Dr. Thaler has received research support from MJFF.
Manan Shah, MD, MBBS	Dr. Shah has nothing to disclose.
Nina H. Kim, MD	Dr. Kim has nothing to disclose.
John G. Kelsey, MD	No disclosure on file
Andrew D. Chang, MS	No disclosure on file
Madhureeta Achari, MD, FAAN	Dr. Achari has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for McKinney-Taylor.
Marcus Cimino, MD	No disclosure on file
Yasmin Aghajan, MD	Dr. Aghajan has nothing to disclose.
Janice Rodriguez Hernandez, MD	No disclosure on file
Juliet K. Knowles, MD	Dr. Knowles has nothing to disclose.
Howard Riina	No disclosure on file
Venkat Jasti	Venkat Jasti has stock in Suven Life Sciences Ltd. Venkat Jasti has received intellectual property interests from a discovery or technology relating to health care.
Anil Shinde	Anil Shinde has received intellectual property interests from a discovery or technology relating to health care.
Savary Om	No disclosure on file
Daniel Freedman, DO	Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedStudy. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Stoll Keenon Ogden.
Jyothsna Ravula	Jyothsna Ravula has nothing to disclose.
John T. Fortunato, MD	No disclosure on file
Yuji Takahashi, MD, PhD	The institution of Dr. Takahashi has received research support from Nihon Medi-Physics Co. Limit.. The institution of Dr. Takahashi has received research support from Takeda Pharmaceutical Company Limited.
Jennifer T. Nguyen, MD	Dr. Nguyen has received research support from Teva Pharmaceuticals LTD.
Masumeh Hatami, MD	No disclosure on file
John M. Schreiber, MD	Dr. Schreiber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Schreiber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon. Dr. Schreiber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zogenix. The institution of Dr. Schreiber has received research support from Dravet Syndrome Foundation.
Jenny L. Rotblat, MD	Ms. Lu has nothing to disclose.
Vivek Barun, DM	Dr. Varun has nothing to disclose.
Rohit Benjamin, MD, DM	No disclosure on file
Ronald Alvarado Dyer, MD	Dr. Alvarado Dyer has nothing to disclose.
Karthik Muthusamy, MBBS	Dr. Muthusamy has nothing to disclose.
Syeda Dania Shujaat, MD, MBBS	No disclosure on file
Sally I. Othman	No disclosure on file
Carlos Eduardo Vervloet Sollero, MD	Dr. Vervloet Sollero has nothing to disclose.
M. M. Paz Soldan, MD, PhD	Dr. Paz Soldan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Paz Soldan has received research support from National Institutes of Health. The institution of Dr. Paz Soldan has received research support from National Multiple Sclerosis Society. The institution of Dr. Paz Soldan has received research support from Western Institute for Biomedical Research. The institution of Dr. Paz Soldan has received research support from Biogen. The institution of Dr. Paz Soldan has received research support from Novartis. The institution of Dr. Paz Soldan has received research support from Clene Nanomedicine.
Romergryko G. Geocadin, MD, FAAN	Dr. Geocadin has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Medicolegal Consulting.
Mefkure Eraksoy, MD	Dr. Eraksoy has nothing to disclose.
Nidhiben A. Anadani, MD	Dr. Anadani has nothing to disclose.
Julia Klein, NP	An immediate family member of Ms. Klein has received personal compensation for serving as an employee of Amgen. An immediate family member of Ms. Klein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen.
Harmehr Sekhon	No disclosure on file
Analia Calle	Analia Calle has nothing to disclose.
Kathleen Shangraw	No disclosure on file
Natalia Rodriguez, MD	Dr. Rodriguez has nothing to disclose.
Caleb Heiberger	No disclosure on file
Smathorn Thakolwiboon, MD	Dr. Thakolwiboon has nothing to disclose.
Steven C. Yang, DO	Dr. Yang has nothing to disclose.
Marie Wencel, CCRP	Ms. Wencel has nothing to disclose.
Farnaz Khalighinejad, MD	Dr. Khalighinejad has nothing to disclose.
Bahareh Adhamimojarad, PhD	No disclosure on file
Zsolt Illes, MD	No disclosure on file
Alexander Keenan	Alexander Keenan has received personal compensation for serving as an employee of Janssen Pharmaceuticals. Alexander Keenan has received stock or an ownership interest from Johnson and Johnson.
Tobias Sejbaek, MD, PhD	Prof. Sejbaek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, Merck, NeuroXpharm, Novartis, Roche, Sandoz and Sanofi. The institution of Prof. Sejbaek has received research support from Merck, Novartis, Roche and Sanofi.
Bahareh Sianati, MD	No disclosure on file
Michael B. Beeler, DO	Dr. Beeler has received personal compensation for serving as an employee of United States Navy.
Ane Skaare Sjulstad, MD	No disclosure on file
Robert J. Ure, MD	No disclosure on file
Harley I. Kornblum, MD, PhD	No disclosure on file
Shirley Ju, MD	No disclosure on file
Junliang Yuan, Sr., MD	No disclosure on file
Thomas G. Brott, MD, FAAN	Dr. Brott has nothing to disclose.
Margie A. Ream, MD, PhD, FAAN	Dr. Ream has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bluebird Bio. Dr. Ream has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for United Council for Neurologic Subspecialties. Dr. Ream has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Rushton, Stakely, Johnston & Garrett, P.A. . Dr. Ream has received personal compensation in the range of $10,000-$49,999 for serving as a Evidence Review Group member with Health Resources and Services Administration. Dr. Ream has received personal compensation in the range of $0-$499 for serving as a Organizational representative with Child Neurology Society.
Ritika Suri, MD	Dr. Suri has nothing to disclose.
Ali M. Al-Salahat, MBBS	Dr. Al-Salahat has nothing to disclose.
Chen Yan, MD	Dr. Yan has nothing to disclose.
Jeffrey Lambe, MD	Dr. Lambe has nothing to disclose.
Rola Khodair, MBBS	Dr. Khodair has nothing to disclose.
Yong Zhang, MD	No disclosure on file
Pratibha Surathi, MD	Dr. Surathi has nothing to disclose.
Leah Millsap, PhD	Dr. Millsap has nothing to disclose.
Heloise Joly	No disclosure on file
Sri Raghav S. Sista, MD	Dr. Sista has nothing to disclose.
Marie-Eve Gendron	Marie-Eve Gendron has received personal compensation for serving as an employee of Merz Therapeutics.
Cristopher Bragg, PhD	No disclosure on file
Jeanne Feuerstein, MD	Dr. Feuerstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceutical. The institution of Dr. Feuerstein has received research support from Mowry Fund Grant. The institution of Dr. Feuerstein has received research support from Davis Phinney. Dr. Feuerstein has received research support from MJFF - Write Now Initiative. Dr. Feuerstein has received personal compensation in the range of $500-$4,999 for serving as a Parkinson's Expert for Legal Case with Keating Wagner Palidori. Dr. Feuerstein has received personal compensation in the range of $100,000-$499,999 for serving as a Attending Neurologist with VAMC. Dr. Feuerstein has received personal compensation in the range of $100,000-$499,999 for serving as a Assistant Professor of Neurology with University of Colorado.
Neethu Gopal, MBBS	No disclosure on file
Stefan Sillau	Stefan Sillau has nothing to disclose.
Yasir Ali, MD, FAAN	Dr. Ali has nothing to disclose.
Matthew Koster	The institution of Matthew Koster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sobi. The institution of Matthew Koster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rigel. The institution of Matthew Koster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. The institution of Matthew Koster has received research support from Sobi.
Juliane Chainakul, APRN-CNS	Juliane Chainakul has nothing to disclose.
Gina S. Perez-Giraldo, MD	Dr. Perez-Giraldo has received personal compensation for serving as an employee of TG therapeutics. Dr. Perez-Giraldo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG therapeutics.
Jamal Al Ali, MD	Dr. Al Ali has nothing to disclose.
Chad J. Swanson	Chad J Swanson has received personal compensation for serving as an employee of Eisai Inc..
Cesar E. Escamilla-Ocanas, MD	Dr. Escamilla-Ocanas has nothing to disclose.
Hanna D. Belay, MD	Dr. Belay has nothing to disclose.
Naomi Nevler, MD	No disclosure on file
Priyanka Madaan	Priyanka Madaan has nothing to disclose.
Amputch Karukote, MD	Dr. Karukote has nothing to disclose.
Rohan Sharma, MD	Dr. Sharma has nothing to disclose.
Lauren A. Neal	Miss Neal has nothing to disclose.
Mohammad O. Nakawah, MD, FAAN	Dr. Nakawah has nothing to disclose.
Shashvat Desai, MD	Dr. Desai has nothing to disclose.
Kenneth Shubin Stein, MD	Dr. Shubin Stein has nothing to disclose.
Justin Rosati, MD	Dr. Rosati has nothing to disclose.
Ahmer Asif, MD	Dr. Asif has nothing to disclose.
Timothy Quezada, MD	Dr. Quezada has nothing to disclose.
Mazen S. Alamr, MBBS	Dr. Alamr has nothing to disclose.
Amanda A. Herrmann, PhD	No disclosure on file
Marcus Vinicius R. Pinto, MD	Dr. Pinto has nothing to disclose.
Sachin M. Kokane	No disclosure on file
Stephen G. Jones, MD	No disclosure on file
Ozgu Kizek, MD	Dr. Kizek has nothing to disclose.
Martin Rabe, MSc	Martin Rabe, M.Sc. has received personal compensation for serving as an employee of Eisai Inc.
Shau Yu Lynch	Shau Yu Lynch has received personal compensation for serving as an employee of AbbVie. Shau Yu Lynch has received personal compensation for serving as an employee of Eisai. Shau Yu Lynch has stock in AbbVie.
Julia Carlson, MD	Dr. Carlson has received publishing royalties from a publication relating to health care.
Sudhindra Vooturi, PT	Dr. Vooturi has nothing to disclose.
Thomas Lawler	No disclosure on file
Rabih Tawk	Rabih Tawk has stock in medtronic.
Sviatoslav Redko, MD	Dr. Redko has nothing to disclose.
Shobha Dhadda	Shobha Dhadda has received personal compensation for serving as an employee of Eisai Inc.
Musab Ali, MD	Dr. Ali has nothing to disclose.
David N. Herrmann, MD, FAAN	Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acceleron. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint global. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Herrmann has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regenacy. Dr. Herrmann has received intellectual property interests from a discovery or technology relating to health care.
Pierre Labauge, MD	Dr. Labauge has nothing to disclose.
Yuehjien Gu, MD	No disclosure on file
Jose L. Torres, MD	Dr. Torres has nothing to disclose.
Shaweta Khosa	Ms. Khosa has nothing to disclose.
Stanley H. Appel, MD, FAAN	Dr. Appel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Appel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eledon. The institution of Dr. Appel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Implicit. The institution of Dr. Appel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Coya Therapeutics. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Muscular Disease Association. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ALS Therapy Development Institute. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ALS Finding a Cure. Dr. Appel has stock in Stock holdings in retirement acct at Fidelity. The institution of Dr. Appel has received research support from Coya Therapeutics.
John Q. Trojanowski, MD, PhD	Dr. Trojanowski has nothing to disclose.
Mustafa S. Siddiqui, MD, FAAN	Dr. Siddiqui has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Boston Scientific Neuromodulation. Dr. Siddiqui has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. The institution of Dr. Siddiqui has received research support from Boston Scientific Neuromodulation. The institution of Dr. Siddiqui has received research support from Abbvie. The institution of Dr. Siddiqui has received research support from National Institute of Health .
Alice Chen-Plotkin, MD	Dr. Chen-Plotkin has received intellectual property interests from a discovery or technology relating to health care.
Muhammad M. Alvi, MD, FAAN	Dr. Alvi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Brainomix.
Jocelyn F. Bautista, MD	No disclosure on file
Carlo Colosimo, MD	No disclosure on file
Jun Shimizu, MD, PhD	No disclosure on file
Vivay Peter Misra, MD	No disclosure on file
Nabeel M. Syed, MBBS	No disclosure on file
Maria V. Diaz Rojas, MD	Dr. Diaz Rojas has nothing to disclose.
Muthu Kuzhali Ganapathy, MBBS	Dr. Ganapathy has nothing to disclose.
Areesha Ahmed, MD	No disclosure on file
Theodore Stem	No disclosure on file
Jitendra Sahu, MD	Jitendra Sahu has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Indian Journal of Pediatrics. The institution of Jitendra Sahu has received research support from Indian Council of Medical Research.
Matthew Smith, MD	Dr. Smith has received personal compensation for serving as an employee of University Health Associates. An immediate family member of Dr. Smith has received personal compensation for serving as an employee of University Health Associates. Dr. Smith has received personal compensation for serving as an employee of West Virginia University. An immediate family member of Dr. Smith has received personal compensation for serving as an employee of West Virginia University. Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Pion, Nerone, Girman, Winslow, & Smith PC. Dr. Smith has received stock or an ownership interest from ROM Technologies.
Pascal Maisonobe	Pascal Maisonobe has received personal compensation for serving as an employee of ipsen pharma. Pascal Maisonobe has received personal compensation for serving as an employee of Ipsen.
Vishank A. Shah, MD	Dr. Shah has nothing to disclose.
Robert Freundlich, MD	Dr. Freundlich has nothing to disclose.
Abdulla Alawadhi, MBBS	Dr. Alawadhi has nothing to disclose.
Imad T. Jarjour, MD, FAAN	No disclosure on file
Carlos Santiago Claverie, MD	No disclosure on file
Danielle B. Cross, MD	No disclosure on file
Mariam Hull, MD	Dr. Hull has received publishing royalties from a publication relating to health care.
Golnoush Akhlaghipour, MD	Dr. Akhlaghipour has nothing to disclose.
Kathryn A. Hart, RN	No disclosure on file
Yair Mina, MD	Dr. Mina has nothing to disclose.
Rebecca Spain, MD, MSPH, FAAN	Dr. Spain has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for United States Department of Justice. The institution of Dr. Spain has received research support from Department of Veterans Affairs. The institution of Dr. Spain has received research support from National Multiple Sclerosis Society.
Gadi Miron	No disclosure on file
Aravindhan Veerapandiyan, MD	Dr. Veerapandiyan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen, Novartis,Edgewise Therapeutics, Pfizer, PTC Therapeutics, Sarepta Therapeutics, Inc., UCB Pharma, Catalyst, Entrada, Lupin, Percheron, ITF. Dr. Veerapandiyan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Veerapandiyan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Muscle and Nerve. The institution of Dr. Veerapandiyan has received research support from AMO Pharma, Capricor Therapeutics, Edgewise Therapeutics, FibroGen, Muscular Dystrophy Association, Novartis, Parent Project Muscular Dystrophy, Pfizer, RegenxBio, SolodBio and Sarepta Therapeutics. Dr. Veerapandiyan has received personal compensation in the range of $5,000-$9,999 for serving as a MD with PPMD, MDA.
Rogelio Dominguez-Moreno, MD	Dr. Dominguez-Moreno has nothing to disclose.
Edward Chang, MD	No disclosure on file
Costantino Iadecola, MD	Dr. Iadecola has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Broadview Ventures.
Santosh B. Murthy, MD	Dr. Murthy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CarePoint. Dr. Murthy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Murthy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Stroke and Neurological disorders. The institution of Dr. Murthy has received research support from National Institutes of Health/NINDS.
Koto Ishida, MD, FAAN	Dr. Ishida has received publishing royalties from a publication relating to health care.
Jon A. Cokley, PharmD	An immediate family member of Dr. Cokley has received personal compensation for serving as an employee of Johnson and Johnson Vision. Dr. Cokley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon Pharmaceuticals. Dr. Cokley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wolters Kluwer. Dr. Cokley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharmaceuticals. Dr. Cokley has received publishing royalties from a publication relating to health care. Dr. Cokley has a non-compensated relationship as a Board of Trustees with Neurocricitical Care Foundation that is relevant to AAN interests or activities.
Guido D. Vazquez II, PhD	Dr. Vazquez has nothing to disclose.
Amanda Sandoval Karamian, MD	The institution of Dr. Sandoval Karamian has received research support from Pediatric Epilepsy Research Foundation.
Veronica Campanille, MD	No disclosure on file
Ray Mirembo	No disclosure on file
Ramakrishna Nirogi, PhD	Dr. Nirogi has nothing to disclose.
Vinod Goyal	Vinod Goyal has received intellectual property interests from a discovery or technology relating to health care.
Pradeep Jayarajan, PhD	Pradeep Jayarajan, PhD has received personal compensation for serving as an employee of Suven Life Sciences Ltd. Pradeep Jayarajan, PhD has or had stock in Suven Life Sciences.Pradeep Jayarajan, PhD has received intellectual property interests from a discovery or technology relating to health care.
Anthony M. Bradshaw, MD	Dr. Bradshaw has nothing to disclose.
Akatsuki Kubota	No disclosure on file
Jie Pan, MD	Dr. Pan has nothing to disclose.
Naohiro Uchio, MD, PhD	No disclosure on file
Satish Jetta	Satish Jetta has received intellectual property interests from a discovery or technology relating to health care.
Peter A. Calabresi, MD, FAAN	Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. An immediate family member of Dr. Calabresi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MyMD. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Myelin Repair Foundation. The institution of Dr. Calabresi has received research support from Genentech. Dr. Calabresi has received publishing royalties from a publication relating to health care. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Grant reveiwer with Myelin Repair Foundation. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker for CME with NYAS. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Academic CME.
Benoit Kullmann, MD	No disclosure on file
Lawanda Esquibel	No disclosure on file
Byrne D. Harper, MD	No disclosure on file
Noam Butterfield, PhD	Dr. Butterfield has received personal compensation for serving as an employee of Xenon Pharmaceuticals.
Celene Grayson, PhD	Dr. Grayson has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Dr. Grayson has stock in Xenon Pharmaceuticals Inc..
Alier Marrero, MD	Dr. Marrero has nothing to disclose.
Mohammed K. Badi, MD	Dr. Badi has nothing to disclose.
Larisa Reyderman	Larisa Reyderman has nothing to disclose.
Constanza Luzon	Constanza Luzon has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Constanza Luzon has stock in Xenon Pharmaceuticals.
Khansa S. Tamboli, Jr., MD	Dr. Tamboli has nothing to disclose.
Merve Atik, MD	Dr. Atik has nothing to disclose.
Paul Miller	No disclosure on file
Matthew Martin, MD	No disclosure on file
Jamie Rumsey, DNP	No disclosure on file
Bruno I. De Almeida	No disclosure on file
Rasha Aldabbagh, MD	No disclosure on file
Salimata Gassama, MD	No disclosure on file
Catherine Daley, MD	Dr. Daley has nothing to disclose.
Yasmin Aziz, MD	Dr. Aziz has nothing to disclose.
Paige Banyas, DO	No disclosure on file
Saeedeh Azary, MD, MPH	No disclosure on file
Michelle Allen-sharpley, MD, PhD	No disclosure on file
Maxime Baud, MD, PhD	No disclosure on file
Chao Xu	Chao Xu has nothing to disclose.
Jamie Bolling	No disclosure on file
Carlyn Patterson Gentile, MD	The institution of Dr. Patterson Gentile has received research support from NIH/NINDS. The institution of Dr. Patterson Gentile has received research support from Children's Hospital of Philadelphia. Dr. Patterson Gentile has received personal compensation in the range of $500-$4,999 for serving as a Faculty, Annual Scientific Meeting, Scottsdale Meeting with American Headache Society. Dr. Patterson Gentile has received personal compensation in the range of $5,000-$9,999 for serving as a Early Career Awardee with American Headache Society. Dr. Patterson Gentile has received personal compensation in the range of $0-$499 for serving as a Research Prize Awardee and travel expense coverage with NIH Pain Consortium. Dr. Patterson Gentile has received personal compensation in the range of $500-$4,999 for serving as a Faculty, Speaker with Headache Cooperative of New England. Dr. Patterson Gentile has received personal compensation in the range of $500-$4,999 for serving as a Speaker, Awardee with ��ɫ��.
Nathan T. Cohen, MD	The institution of Dr. Cohen has received research support from ��ɫ�� (Career Development Award). The institution of Dr. Cohen has received research support from Pediatric Epilepsy Research Foundation/Child Neurology Foundation (Shields Research Grant). Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker (Honorarium) with American Academy of Pediatrics. Dr. Cohen has a non-compensated relationship as a Member (Editorial Board) with Neurology: Clinical Practice that is relevant to AAN interests or activities. Dr. Cohen has a non-compensated relationship as a Member (Scientific Program Committee, Pediatric Content Committee) with American Epilepsy Society that is relevant to AAN interests or activities. Dr. Cohen has a non-compensated relationship as a Member (Research and Training Council, Investigators Workshop Committee, Pediatric Content Committee) with American Epilepsy Scoiety that is relevant to AAN interests or activities.

��ɫ����

��ɫ����

��ɫ��

��ɫ��